NVIDIA
NVDA
Disney
DIS
Cisco
CSCO
ASML Holding
ASML
Apple
AAPL
US Stock MarketDetailed Quotes
COCP Cocrystal Pharma
- 2.1100
- +0.1300+6.57%
Close Dec 18 16:00 ET
21.47MMarket Cap-1.15P/E (TTM)
2.3000High1.9000Low93.56KVolume1.9700Open1.9800Pre Close201.57KTurnover1.33%Turnover RatioLossP/E (Static)10.17MShares3.100052wk High1.69P/B14.80MFloat Cap1.325052wk Low--Dividend TTM7.01MShs Float77.4000Historical High--Div YieldTTM20.20%Amplitude1.3250Historical Low2.1540Avg Price1Lot Size
Cocrystal Pharma Stock Forum
Sign in to post a comment
$ABVC BioPharma (ABVC.US)$ - Progress continues in our ADHD program with Phase IIb trials at multiple prominent sites. We aim to have an interim report by Q4 2024. ABV-1601 for MDD in cancer patients has completed Phase I study preparation, including the Site Initiation Visit (SIV). The study is set to initiate by the end of 2024.
$Ascent Solar Technologies (ASTI.US)$- Following delivery and the successful completion of the on-orbi...
$Ascent Solar Technologies (ASTI.US)$- Following delivery and the successful completion of the on-orbi...
25
7
7
$Cocrystal Pharma (COCP.US)$
Cocrystal Pharma Reports Favorable Results from Single-Ascending Dose Cohorts of Phase 1 Study with CDI-988, its Oral Pan-Viral Norovirus/Coronavirus Protease Inhibitor
Cocrystal Pharma (Nasdaq: COCP) reported favorable safety and tolerability results from the single-ascending dose (SAD) cohorts of its Phase 1 study for CDI-988, an oral pan-viral norovirus/coronavirus protease inhibitor.
The study, conducted in Australia, evaluated doses ranging from 100 mg to 60...
Cocrystal Pharma Reports Favorable Results from Single-Ascending Dose Cohorts of Phase 1 Study with CDI-988, its Oral Pan-Viral Norovirus/Coronavirus Protease Inhibitor
Cocrystal Pharma (Nasdaq: COCP) reported favorable safety and tolerability results from the single-ascending dose (SAD) cohorts of its Phase 1 study for CDI-988, an oral pan-viral norovirus/coronavirus protease inhibitor.
The study, conducted in Australia, evaluated doses ranging from 100 mg to 60...
$Cocrystal Pharma (COCP.US)$
NEWS
Enrollment Completed in Phase 2a Study with Cocrystal Pharma’s Oral Antiviral Candidate CC-42344 for Pandemic and Seasonal Influenza
NEWS
Enrollment Completed in Phase 2a Study with Cocrystal Pharma’s Oral Antiviral Candidate CC-42344 for Pandemic and Seasonal Influenza
$Cocrystal Pharma (COCP.US)$ If I become CEO, I will take away the P and put a K in the ticker. Thank you everyone
follow for nightly watchlist ![]()
FNGR still going
$AeroClean Technologies (AERC.US)$ $Bit Brother (BTB.US)$ $Cocrystal Pharma (COCP.US)$ $FingerMotion (FNGR.US)$ $GLOBAL TECH INDUSTRIES GROUP INC (GTII.US)$ $Home Depot (HD.US)$ $Oncternal Therapeutics (ONCT.US)$ $Pinterest (PINS.US)$ $Rivian Automotive (RIVN.US)$ $Snap Inc (SNAP.US)$ $SOBR Safe (SOBR.US)$ $Twitter (Delisted) (TWTR.US)$
$AeroClean Technologies (AERC.US)$ $Bit Brother (BTB.US)$ $Cocrystal Pharma (COCP.US)$ $FingerMotion (FNGR.US)$ $GLOBAL TECH INDUSTRIES GROUP INC (GTII.US)$ $Home Depot (HD.US)$ $Oncternal Therapeutics (ONCT.US)$ $Pinterest (PINS.US)$ $Rivian Automotive (RIVN.US)$ $Snap Inc (SNAP.US)$ $SOBR Safe (SOBR.US)$ $Twitter (Delisted) (TWTR.US)$
8
1
$Cocrystal Pharma (COCP.US)$ Newswires) -- Cocrystal Pharma, Inc. (COCP) dijo el jueves que completó la porción de dosis única ascendente de un estudio de fase 1 del candidato antiviral CC-42344 para tratar la influenza pandémica y estacional y que los datos respaldan el potencial de una dosis diaria dosificación
La compañía de biotecnología dijo que los sujetos se están inscribiendo actualmente en la porción de dosis ascendente múltiple del estudio de fase 1. El estudio se lleva a cabo en Au...
La compañía de biotecnología dijo que los sujetos se están inscribiendo actualmente en la porción de dosis ascendente múltiple del estudio de fase 1. El estudio se lleva a cabo en Au...
No comment yet
Trending US Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
AddiBee0925 : Hey Jag. Just a heads up. If all goes as planned, the launch for SIDU and SpaceX is on the schedule for this Friday on the 20th. I wouldn't think that it would be rescheduled so soon to the launch, at least no report has said otherwise.
Jaguar8 OP AddiBee0925 : Yes. But there might be a build up of the price before the launch just like LUNR. Hopefully it goes well.
AddiBee0925 Jaguar8 OP : yeah I'm thinking the same
Jaguar8 OP browny_440 : TNXP will be good if FDA releases decision soon
72306783 : I would like to ask, what signals or standards do you use to start building positions? I am still learning... Thank you very much for your Share
View more comments...